Related Experiment Video
Updated: Feb 6, 2026

Orthotopic Mouse Model of Colorectal Cancer
Published on: December 4, 2007
Eastern Canadian Colorectal Cancer Consensus Conference 2017
S F McGee1, W AlGhareeb1, C H Ahmad2
1Ontario-The Ottawa Hospital Cancer Centre, Ottawa (AlGhareeb, Asmis, Goel, Hyde, Jonker, Marginean, McGee, Vickers); Queen's University and Cancer Centre of Southeastern Ontario, Kingston (Biagi, Booth, Virik); Princess Margaret Cancer Centre, Toronto (Dawson); St. Michael's Hospital, Toronto (Babak); Sunnybrook Odette Cancer Centre, University of Toronto, Toronto (Berry); Cancer Centre of Southeastern Ontario, Kingston (Mahmud); Queensway Health Centre, Toronto (Muinuddin); Colorectal Cancer Canada, North York (Servidio-Italiano); Grand River Regional Cancer Centre, Kitchener (Tsvetkova, Valdes); London Health Sciences Centre, London (Welch).
This consensus statement provides updated recommendations for managing gastrointestinal cancers, focusing on hereditary colorectal cancer (CRC), gastric cancer, and rectal cancer treatment strategies.
Area of Science:
- Gastroenterology and Oncology
- Cancer Genetics
- Clinical Practice Guidelines
Background:
- The Eastern Canadian Gastrointestinal Cancer Consensus Conference 2017 convened experts in oncology and genetics.
- The conference focused on advancing the management of gastric, rectal, and colon cancers.
Implications:
- Provides evidence-based recommendations for clinical practice in gastrointestinal oncology.
- Aims to improve patient outcomes through optimized treatment strategies for gastric, rectal, and colon cancers.
- Highlights the importance of molecular markers and hereditary cancer identification in CRC management.
Related Concept Videos
Cancer
What is Cancer?
Although people have known about cancer for centuries, it was only in 1761 that Giovanni Morgagni of Padua performed a detailed autopsy of...
Cancer Prevention
Some...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Gene Flow
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...

